Skip to main content
Top
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Whooping Cough | Research article

Influenza and pertussis vaccination during pregnancy – attitudes, practices and barriers in gynaecological practices in Germany

Authors: Stefanie Böhm, Marianne Röbl-Mathieu, Burkhard Scheele, Michael Wojcinski, Ole Wichmann, Wiebke Hellenbrand

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

In Germany, antenatal influenza vaccination is recommended since 2010, but uptake remains low. Several countries recently introduced antenatal pertussis vaccination, which is currently under consideration in Germany. We conducted a survey among gynaecologists on attitudes, practices and barriers regarding influenza and pertussis vaccination during pregnancy.

Methods

Gynaecologists were invited to complete a pre-tested, 24-item questionnaire published in the German Professional Association of Gynaecologists’ journal in September 2017 within 2 months. Associations between variables were examined using Chi-Squared, Fischer’s Exact or t-tests. Variables associated with gynaecologists’ self-reported implementation of vaccination in pregnant women were identified using univariate and multivariate logistic regression analyses.

Results

Of 867 participants (response 11%), 91.4 and 59.4% reported currently vaccinating pregnant women against influenza and pertussis, respectively. Gynaecologists who reported obtaining annual influenza vaccination and actively informing their patients about these vaccinations were significantly more likely to vaccinate pregnant women against influenza (96.5% vs. 65.7 and 95.1% vs. 62.2%) and pertussis (63.1% vs. 44.3 and 82.4% vs. 12.9%). Performing influenza vaccination was least likely among gynaecologists who perceived logistical difficulties as a vaccination barrier (35.9%), while pertussis vaccination was least likely if the lacking official recommendation (32.0%), logistical difficulties (27.1%), safety concerns (17.5%) and limited vaccine effectiveness (11.1%) were perceived as barriers. Of participants not yet vaccinating pregnant women against pertussis, 86.5% reported they would follow an official recommendation. Including vaccination recommendations in the maternity record (95.2%) and informing the public (88.7%) and health care professionals (86.6%) were considered the most suitable measures to achieve high pertussis vaccination coverage.

Conclusions

The large proportion reporting performance of influenza vaccination during pregnancy and high acceptance of a potential recommendation for pertussis vaccination reflected positive attitudes towards vaccination among participants. However, factors associated with failure to vaccinate may be more prevalent among non-participants. Results suggest that gynaecologists’ confidence in vaccination is crucial for implementing vaccination in pregnancy. Thus, doubts on vaccine effectiveness and safety should be allayed among gynaecologists and pregnant women via various communication channels, and solutions for logistical barriers sought. Including antenatal vaccination recommendations in the maternity record would serve as an important reminder for both groups.
Appendix
Available only for authorised users
Literature
1.
go back to reference Robert Koch Institute. RKI guide for physicians. Epidemiologisches Bulletin. 2016;7:57–63 in German. Robert Koch Institute. RKI guide for physicians. Epidemiologisches Bulletin. 2016;7:57–63 in German.
2.
go back to reference Robert Koch Institute. Communication of the Standing Commission on Vaccination (STIKO) at the Robert Koch Institute - Amendment of the Recommendations on Vaccination against Influenza. Epidemiologisches Bulletin. 2010;31:299–314 in German. Robert Koch Institute. Communication of the Standing Commission on Vaccination (STIKO) at the Robert Koch Institute - Amendment of the Recommendations on Vaccination against Influenza. Epidemiologisches Bulletin. 2010;31:299–314 in German.
3.
go back to reference Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ. 2007;176(4):463–8.PubMedPubMedCentralCrossRef Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ. 2007;176(4):463–8.PubMedPubMedCentralCrossRef
4.
go back to reference Mertz D, Geraci J, Winkup J, Gessner BD, Ortiz JR, Loeb M. Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies. Vaccine. 2017;35(4):521–8.PubMedPubMedCentralCrossRef Mertz D, Geraci J, Winkup J, Gessner BD, Ortiz JR, Loeb M. Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies. Vaccine. 2017;35(4):521–8.PubMedPubMedCentralCrossRef
5.
go back to reference Buda S, Kopke K, Haas W. Epidemiological characteristics of the influenza pandemic (H1N1) 2009 in Germany based on the mandatory notification of cases. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010;53(12):1223–30 (in German with English summary).PubMedCrossRef Buda S, Kopke K, Haas W. Epidemiological characteristics of the influenza pandemic (H1N1) 2009 in Germany based on the mandatory notification of cases. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010;53(12):1223–30 (in German with English summary).PubMedCrossRef
6.
go back to reference Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, et al. Risk factors for severe outcomes following 2009 influenza a (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8(7):e1001053.PubMedPubMedCentralCrossRef Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, et al. Risk factors for severe outcomes following 2009 influenza a (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8(7):e1001053.PubMedPubMedCentralCrossRef
7.
go back to reference Mazagatos C, Delgado-Sanz C, Oliva J, Gherasim A, Larrauri A, Spanish Influenza Surveillance System. Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11–2015/16. PLoS One. 2018;13(8):e0200934.PubMedPubMedCentralCrossRef Mazagatos C, Delgado-Sanz C, Oliva J, Gherasim A, Larrauri A, Spanish Influenza Surveillance System. Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11–2015/16. PLoS One. 2018;13(8):e0200934.PubMedPubMedCentralCrossRef
8.
go back to reference Remschmidt C, Harder T, Wichmann O, Garbe E, Ledig T, Terhardt M, et al. Background paper of STIKO: evaluation of the existing influenza vaccination recommendation for indication groups and for seniors (standard vaccination from 60 years). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016;59(12):1606–22 (in German).PubMedCrossRef Remschmidt C, Harder T, Wichmann O, Garbe E, Ledig T, Terhardt M, et al. Background paper of STIKO: evaluation of the existing influenza vaccination recommendation for indication groups and for seniors (standard vaccination from 60 years). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016;59(12):1606–22 (in German).PubMedCrossRef
9.
go back to reference Fell DB, Azziz-Baumgartner E, Baker MG, Batra M, Beauté J, Beutels P, et al. Influenza epidemiology and immunization during pregnancy: final report of a World Health Organization working group. Vaccine. 2017;35(43):5738–50.PubMedCrossRef Fell DB, Azziz-Baumgartner E, Baker MG, Batra M, Beauté J, Beutels P, et al. Influenza epidemiology and immunization during pregnancy: final report of a World Health Organization working group. Vaccine. 2017;35(43):5738–50.PubMedCrossRef
10.
go back to reference Horstkötter N, Müller U, Ommen O, Platte A, Reckendrees B, Stander V, et al. Attitudes, knowledge and behaviour of adults and parents towards vaccinations - results of the representative survey 2016 on infection protection. Köln: Bundeszentrale für gesundheitliche Aufklärung; 2017. (in German) Horstkötter N, Müller U, Ommen O, Platte A, Reckendrees B, Stander V, et al. Attitudes, knowledge and behaviour of adults and parents towards vaccinations - results of the representative survey 2016 on infection protection. Köln: Bundeszentrale für gesundheitliche Aufklärung; 2017. (in German)
11.
go back to reference Bödeker B, Walter D, Reiter S, Wichmann O. Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany. Vaccine. 2014;32(33):4131–9.PubMedCrossRef Bödeker B, Walter D, Reiter S, Wichmann O. Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany. Vaccine. 2014;32(33):4131–9.PubMedCrossRef
12.
go back to reference Baum S, Hitschold T, Becker A, Smola S, Solomayer E, Rody A, et al. Implementation of the recommendation to vaccinate pregnant women against seasonal influenza - vaccination rates and acceptance. Geburtshilfe Frauenheilkd. 2017;77(4):340–51.PubMedPubMedCentralCrossRef Baum S, Hitschold T, Becker A, Smola S, Solomayer E, Rody A, et al. Implementation of the recommendation to vaccinate pregnant women against seasonal influenza - vaccination rates and acceptance. Geburtshilfe Frauenheilkd. 2017;77(4):340–51.PubMedPubMedCentralCrossRef
13.
go back to reference Bödeker B, Betsch C, Wichmann O. Skewed risk perceptions in pregnant women: the case of influenza vaccination. BMC Public Health. 2015;16:1308.PubMedCrossRef Bödeker B, Betsch C, Wichmann O. Skewed risk perceptions in pregnant women: the case of influenza vaccination. BMC Public Health. 2015;16:1308.PubMedCrossRef
14.
go back to reference European Centre for Disease Prevention and Control. Seasonal influenza immunisation in Europe. Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007–2008 to 2014–2015. Stockholm: ECDC; 2017. European Centre for Disease Prevention and Control. Seasonal influenza immunisation in Europe. Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007–2008 to 2014–2015. Stockholm: ECDC; 2017.
15.
go back to reference Gill C, Rohani P, Thea DM. The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis. F1000Research. 2017;6:1568.PubMedPubMedCentralCrossRef Gill C, Rohani P, Thea DM. The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis. F1000Research. 2017;6:1568.PubMedPubMedCentralCrossRef
16.
go back to reference Robert Koch Institute. Situation of selected infectious diseases in Germany - whooping cough diseases in the new federal states, 2002 to 2012. Epidemiologisches Bulletin. 2014;1:1–14 (in German). Robert Koch Institute. Situation of selected infectious diseases in Germany - whooping cough diseases in the new federal states, 2002 to 2012. Epidemiologisches Bulletin. 2014;1:1–14 (in German).
17.
go back to reference Robert Koch Institute. Workshop Report: Three years of national pertussis notification - exchange of experience between the public health service, the medical profession and participating laboratories to identify measures for improving surveillance. Epidemiologisches Bulletin. 2017;21:187–200 in German. Robert Koch Institute. Workshop Report: Three years of national pertussis notification - exchange of experience between the public health service, the medical profession and participating laboratories to identify measures for improving surveillance. Epidemiologisches Bulletin. 2017;21:187–200 in German.
18.
go back to reference Fulton TR, Phadke VK, Orenstein WA, Hinman AR, Johnson WD, Omer SB. Protective effect of contemporary pertussis vaccines: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(9):1100–10.PubMedPubMedCentralCrossRef Fulton TR, Phadke VK, Orenstein WA, Hinman AR, Johnson WD, Omer SB. Protective effect of contemporary pertussis vaccines: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(9):1100–10.PubMedPubMedCentralCrossRef
19.
go back to reference McGirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics. 2015;135(2):331–43.PubMedCrossRef McGirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics. 2015;135(2):331–43.PubMedCrossRef
20.
go back to reference Hartzell JD, Blaylock JM. Whooping cough in 2014 and beyond: an update and review. Chest. 2014;146(1):205–14.PubMedCrossRef Hartzell JD, Blaylock JM. Whooping cough in 2014 and beyond: an update and review. Chest. 2014;146(1):205–14.PubMedCrossRef
21.
go back to reference Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326–82.PubMedPubMedCentralCrossRef Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326–82.PubMedPubMedCentralCrossRef
22.
go back to reference Schielke A, Takla A, von Kries R, Wichmann O, Hellenbrand W. Marked under-reporting of pertussis requiring hospitalization in infants as estimated by capture-recapture methodology, Germany, 2013-2015. Pediatr Infect Dis J. 2017;37(2):119–25.CrossRef Schielke A, Takla A, von Kries R, Wichmann O, Hellenbrand W. Marked under-reporting of pertussis requiring hospitalization in infants as estimated by capture-recapture methodology, Germany, 2013-2015. Pediatr Infect Dis J. 2017;37(2):119–25.CrossRef
23.
go back to reference Robert Koch-Institut. Infection epidemiological yearbook of notifiable diseases for 2016. Berlin: Robert Koch-Institut; 2017. (in German) Robert Koch-Institut. Infection epidemiological yearbook of notifiable diseases for 2016. Berlin: Robert Koch-Institut; 2017. (in German)
24.
go back to reference Robert Koch Institute. [Case definitions for the transmission of cases of illness and death as well as pathogen detection of mumps, pertussis, rubella and varicella]. Bundesgesundheitsblatt. 2013:1–14. (in German). Robert Koch Institute. [Case definitions for the transmission of cases of illness and death as well as pathogen detection of mumps, pertussis, rubella and varicella]. Bundesgesundheitsblatt. 2013:1–14. (in German).
25.
go back to reference Robert Koch Institute. Recommendations of the Standing Vaccination Commission (STIKO) at RKI 2016/2017. Epidemiologisches Bulletin. 2016;34:301–40 (in German). Robert Koch Institute. Recommendations of the Standing Vaccination Commission (STIKO) at RKI 2016/2017. Epidemiologisches Bulletin. 2016;34:301–40 (in German).
26.
go back to reference Böhmer MM, Hellenbrand W, Matysiak-Klose D, Heininger U, Muters S, Wichmann O. Pertussis vaccination coverage among adults in Germany. Dtsch Med Wochenschr. 2013;138(28–29):1451–7 (in German with English summary).PubMed Böhmer MM, Hellenbrand W, Matysiak-Klose D, Heininger U, Muters S, Wichmann O. Pertussis vaccination coverage among adults in Germany. Dtsch Med Wochenschr. 2013;138(28–29):1451–7 (in German with English summary).PubMed
27.
go back to reference Bödeker B, Remschmidt C, Muters S, Wichmann O. Influenza, tetanus, and pertussis vaccination coverage among adults in Germany. Bundesgesundheitsbla. 2015;58(2):174–81 (in German with English summary).CrossRef Bödeker B, Remschmidt C, Muters S, Wichmann O. Influenza, tetanus, and pertussis vaccination coverage among adults in Germany. Bundesgesundheitsbla. 2015;58(2):174–81 (in German with English summary).CrossRef
28.
go back to reference Skowronski DM, Janjua NZ, Sonfack Tsafack EP, Ouakki M, Hoang L, De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis. 2012;54(3):318–27.PubMedCrossRef Skowronski DM, Janjua NZ, Sonfack Tsafack EP, Ouakki M, Hoang L, De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis. 2012;54(3):318–27.PubMedCrossRef
29.
go back to reference Urwyler P, Heininger U. Protecting newborns from pertussis - the challenge of complete cocooning. BMC Infectious Diseases. 2014;14:1.CrossRef Urwyler P, Heininger U. Protecting newborns from pertussis - the challenge of complete cocooning. BMC Infectious Diseases. 2014;14:1.CrossRef
30.
go back to reference Mary Healy C, Rench MA, Wootton SH, Castagnini LA. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J. 2015;34(1):22–6.PubMedCrossRef Mary Healy C, Rench MA, Wootton SH, Castagnini LA. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J. 2015;34(1):22–6.PubMedCrossRef
31.
go back to reference Carcione D, Regan AK, Tracey L, Mak DB, Gibbs R, Dowse GK, et al. The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia. Vaccine. 2015;33(42):5654–61.PubMedCrossRef Carcione D, Regan AK, Tracey L, Mak DB, Gibbs R, Dowse GK, et al. The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia. Vaccine. 2015;33(42):5654–61.PubMedCrossRef
32.
go back to reference Blain AE, Lewis M, Banerjee E, Kudish K, Liko J, McGuire S, et al. An assessment of the cocooning strategy for preventing infant pertussis-United States, 2011. Clin Infect Dis. 2016;63:S221–S6.PubMedPubMedCentralCrossRef Blain AE, Lewis M, Banerjee E, Kudish K, Liko J, McGuire S, et al. An assessment of the cocooning strategy for preventing infant pertussis-United States, 2011. Clin Infect Dis. 2016;63:S221–S6.PubMedPubMedCentralCrossRef
33.
go back to reference Gkentzi D, Katsakiori P, Marangos M, Hsia Y, Amirthalingam G, Heath PT, et al. Maternal vaccination against pertussis: a systematic review of the recent literature. Arch Dis Child Fetal Neonatal Ed. 2017;102(5):F456–F63.PubMedCrossRef Gkentzi D, Katsakiori P, Marangos M, Hsia Y, Amirthalingam G, Heath PT, et al. Maternal vaccination against pertussis: a systematic review of the recent literature. Arch Dis Child Fetal Neonatal Ed. 2017;102(5):F456–F63.PubMedCrossRef
34.
go back to reference Furuta M, Sin J, Ng ESW, Wang K. Efficacy and safety of pertussis vaccination for pregnant women - a systematic review of randomised controlled trials and observational studies. BMC pregnancy and childbirth. 2017;17(1):390.PubMedPubMedCentralCrossRef Furuta M, Sin J, Ng ESW, Wang K. Efficacy and safety of pertussis vaccination for pregnant women - a systematic review of randomised controlled trials and observational studies. BMC pregnancy and childbirth. 2017;17(1):390.PubMedPubMedCentralCrossRef
35.
go back to reference Winter K, Nickell S, Powell M, Harriman K. Effectiveness of prenatal versus postpartum tetanus, diphtheria, and acellular pertussis vaccination in preventing infant pertussis. Clin Infect Dis. 2017;64(1):3–8.PubMedCrossRef Winter K, Nickell S, Powell M, Harriman K. Effectiveness of prenatal versus postpartum tetanus, diphtheria, and acellular pertussis vaccination in preventing infant pertussis. Clin Infect Dis. 2017;64(1):3–8.PubMedCrossRef
36.
go back to reference Winter K, Cherry JD, Harriman K. Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants. Clin Infect Dis. 2017;64(1):9–14.PubMedCrossRef Winter K, Cherry JD, Harriman K. Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants. Clin Infect Dis. 2017;64(1):9–14.PubMedCrossRef
37.
go back to reference Skoff TH, Blain AE, Watt J, Scherzinger K, McMahon M, Zansky SM, et al. Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation. Clin Infect Dis. 2017;65(12):1977–83.PubMedPubMedCentralCrossRef Skoff TH, Blain AE, Watt J, Scherzinger K, McMahon M, Zansky SM, et al. Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation. Clin Infect Dis. 2017;65(12):1977–83.PubMedPubMedCentralCrossRef
38.
go back to reference Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis. 2015;60(3):333–7.PubMedCrossRef Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis. 2015;60(3):333–7.PubMedCrossRef
39.
go back to reference Bellido-Blasco J, Guiral-Rodrigo S, Míguez-Santiyán A, Salazar-Cifre A, González-Morán F. A case–control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016. Eurosurveillance. 2017;22:22.CrossRef Bellido-Blasco J, Guiral-Rodrigo S, Míguez-Santiyán A, Salazar-Cifre A, González-Morán F. A case–control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016. Eurosurveillance. 2017;22:22.CrossRef
40.
go back to reference Baxter R, Bartlett J, Fireman B, Lewis E, Klein NP. Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics. 2017;139:5.CrossRef Baxter R, Bartlett J, Fireman B, Lewis E, Klein NP. Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics. 2017;139:5.CrossRef
41.
go back to reference Amirthalingam G, Campbell H, Ribeiro S, Fry NK, Ramsay M, Miller E, et al. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clin Infect Dis. 2016;63:S236–S43.PubMedPubMedCentralCrossRef Amirthalingam G, Campbell H, Ribeiro S, Fry NK, Ramsay M, Miller E, et al. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clin Infect Dis. 2016;63:S236–S43.PubMedPubMedCentralCrossRef
42.
go back to reference Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384(9953):1521–8.PubMedCrossRef Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384(9953):1521–8.PubMedCrossRef
43.
go back to reference Saul N, Wang K, Bag S, Baldwin H, Alexander K, Chandra M, et al. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW public health network case-control study. Vaccine. 2018;36(14):1887–92.PubMedCrossRef Saul N, Wang K, Bag S, Baldwin H, Alexander K, Chandra M, et al. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW public health network case-control study. Vaccine. 2018;36(14):1887–92.PubMedCrossRef
44.
go back to reference Abu Raya B, Edwards KM, Scheifele DW, Halperin SA. Pertussis and influenza immunisation during pregnancy: a landscape review. Lancet Infect Dis. 2017;17(7):e209–e22.PubMedCrossRef Abu Raya B, Edwards KM, Scheifele DW, Halperin SA. Pertussis and influenza immunisation during pregnancy: a landscape review. Lancet Infect Dis. 2017;17(7):e209–e22.PubMedCrossRef
45.
go back to reference McMillan M, Clarke M, Parrella A, Fell DB, Amirthalingam G, Marshall HS. Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy a systematic review. Obstet Gynecol. 2017;129(3):560–73.PubMedCrossRef McMillan M, Clarke M, Parrella A, Fell DB, Amirthalingam G, Marshall HS. Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy a systematic review. Obstet Gynecol. 2017;129(3):560–73.PubMedCrossRef
47.
go back to reference STIKO. [Standard procedure (SOP) of the Standing Commission on Vaccination (STIKO) for the systematic development of vaccination recommendations]. Berlin; 2016. (in German). STIKO. [Standard procedure (SOP) of the Standing Commission on Vaccination (STIKO) for the systematic development of vaccination recommendations]. Berlin; 2016. (in German).
49.
go back to reference Bundesärztekammer. Medical statistics as of 31 December 2016. Berlin: Bundesärztekammer; 2016. (in German) Bundesärztekammer. Medical statistics as of 31 December 2016. Berlin: Bundesärztekammer; 2016. (in German)
50.
go back to reference Bödeker B, Seefeld L, Buck S, Ommen O, Wichmann O. Implementation of seasonal influenza and human papillomavirus vaccination recommendations in gynecological practices in Germany. Bundesgesundheitsblatt. 2016;59(3):396–404 (in German with English summary).CrossRef Bödeker B, Seefeld L, Buck S, Ommen O, Wichmann O. Implementation of seasonal influenza and human papillomavirus vaccination recommendations in gynecological practices in Germany. Bundesgesundheitsblatt. 2016;59(3):396–404 (in German with English summary).CrossRef
51.
go back to reference Stark LM, Power ML, Turrentine M, Samelson R, Siddiqui MM, Paglia MJ, et al. Influenza vaccination among pregnant women: patient beliefs and medical provider practices. Infect Dis Obstet Gynecol. 2016;2016:3281975.PubMedPubMedCentralCrossRef Stark LM, Power ML, Turrentine M, Samelson R, Siddiqui MM, Paglia MJ, et al. Influenza vaccination among pregnant women: patient beliefs and medical provider practices. Infect Dis Obstet Gynecol. 2016;2016:3281975.PubMedPubMedCentralCrossRef
52.
go back to reference Vishram B, Letley L, Jan Van Hoek A, Silverton L, Donovan H, Adams C, et al. Vaccination in pregnancy: Attitudes of nurses, midwives and health visitors in England. Hum Vaccin Immunother. 2017:1–10. Vishram B, Letley L, Jan Van Hoek A, Silverton L, Donovan H, Adams C, et al. Vaccination in pregnancy: Attitudes of nurses, midwives and health visitors in England. Hum Vaccin Immunother. 2017:1–10.
53.
go back to reference Strassberg ER, Power M, Schulkin J, Stark LM, Mackeen AD, Murtough KL, et al. Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy. Vaccine. 2018;36(30):4548–54.PubMedCrossRef Strassberg ER, Power M, Schulkin J, Stark LM, Mackeen AD, Murtough KL, et al. Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy. Vaccine. 2018;36(30):4548–54.PubMedCrossRef
54.
go back to reference WHO SAGE Working Group. Report of the SAGE working group on vaccine hestitancy. WHO; 2014. WHO SAGE Working Group. Report of the SAGE working group on vaccine hestitancy. WHO; 2014.
55.
go back to reference Bonville CA, Cibula DA, Domachowske JB, Suryadevara M. Vaccine attitudes and practices among obstetric providers in New York state following the recommendation for pertussis vaccination during pregnancy. Hum Vaccin Immunother. 2015;11(3):713–8.PubMedPubMedCentralCrossRef Bonville CA, Cibula DA, Domachowske JB, Suryadevara M. Vaccine attitudes and practices among obstetric providers in New York state following the recommendation for pertussis vaccination during pregnancy. Hum Vaccin Immunother. 2015;11(3):713–8.PubMedPubMedCentralCrossRef
56.
go back to reference Lu AB, Abd Halim A, Dendle C, Kotsanas D, Giles ML, Wallace EM, et al. Influenza vaccination uptake amongst pregnant women and maternal care providers is suboptimal. Vaccine. 2012;30(27):4055–9.PubMedCrossRef Lu AB, Abd Halim A, Dendle C, Kotsanas D, Giles ML, Wallace EM, et al. Influenza vaccination uptake amongst pregnant women and maternal care providers is suboptimal. Vaccine. 2012;30(27):4055–9.PubMedCrossRef
57.
go back to reference Ganczak M, Gil K, Korzen M, Bazydlo M. Coverage and Influencing Determinants of Influenza Vaccination in Elderly Patients in a Country with a Poor Vaccination Implementation. Int J Environ Res Public Health. 2017;14:6. Ganczak M, Gil K, Korzen M, Bazydlo M. Coverage and Influencing Determinants of Influenza Vaccination in Elderly Patients in a Country with a Poor Vaccination Implementation. Int J Environ Res Public Health. 2017;14:6.
58.
go back to reference Ding H, Black CL, Ball S, Fink RV, Williams WW, Parker Fiebelkorn A, et al. Influenza Vaccination Coverage Among Pregnant Women — United States, 2016–17 Influenza Season. U.S. Centers for Disease Control and Prevention (CDC) 2017. Ding H, Black CL, Ball S, Fink RV, Williams WW, Parker Fiebelkorn A, et al. Influenza Vaccination Coverage Among Pregnant Women — United States, 2016–17 Influenza Season. U.S. Centers for Disease Control and Prevention (CDC) 2017.
59.
go back to reference Sricharoenchai S, Sirivichayakul C, Chokephaibulkit K, Pitisuttithum P, Dhitavat J, Pitisuthitham A, et al. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial. Lancet Infect Dis. 2018;18(1):58–67.PubMedCrossRef Sricharoenchai S, Sirivichayakul C, Chokephaibulkit K, Pitisuttithum P, Dhitavat J, Pitisuthitham A, et al. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial. Lancet Infect Dis. 2018;18(1):58–67.PubMedCrossRef
60.
go back to reference Blanchard Rohner G, Chatzis O, Chinwangso P, Rohr M, Grillet S, Salomon C, et al. Boosting teenagers with acellular pertussis vaccines containing recombinant or chemically inactivated pertussis toxin: a randomized clinical trial. Clinical Infectious Diseases. 2018;68(7):1213–22.CrossRef Blanchard Rohner G, Chatzis O, Chinwangso P, Rohr M, Grillet S, Salomon C, et al. Boosting teenagers with acellular pertussis vaccines containing recombinant or chemically inactivated pertussis toxin: a randomized clinical trial. Clinical Infectious Diseases. 2018;68(7):1213–22.CrossRef
61.
go back to reference Heininger U. Is there a need for a stand-alone acellular pertussis vaccine? Pediatr Infect Dis J. 2018;37(4):359–60.PubMedCrossRef Heininger U. Is there a need for a stand-alone acellular pertussis vaccine? Pediatr Infect Dis J. 2018;37(4):359–60.PubMedCrossRef
62.
go back to reference Winslade CG, Heffernan CM, Atchison CJ. Experiences and perspectives of mothers of the pertussis vaccination programme in London. Public Health. 2017;146:10–4.PubMedCrossRef Winslade CG, Heffernan CM, Atchison CJ. Experiences and perspectives of mothers of the pertussis vaccination programme in London. Public Health. 2017;146:10–4.PubMedCrossRef
63.
go back to reference Klatt TE, Hopp E. Effect of a best-practice alert on the rate of influenza vaccination of pregnant women. Obstet Gynecol. 2012;119(2 Pt 1):301–5.PubMedCrossRef Klatt TE, Hopp E. Effect of a best-practice alert on the rate of influenza vaccination of pregnant women. Obstet Gynecol. 2012;119(2 Pt 1):301–5.PubMedCrossRef
64.
go back to reference Morgan JL, Baggari SR, Chung W, Ritch J, McIntire DD, Sheffield JS. Association of a Best-Practice Alert and Prenatal Administration with Tetanus Toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination rates. Obstet Gynecol. 2015;126(2):333–7.PubMedCrossRef Morgan JL, Baggari SR, Chung W, Ritch J, McIntire DD, Sheffield JS. Association of a Best-Practice Alert and Prenatal Administration with Tetanus Toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination rates. Obstet Gynecol. 2015;126(2):333–7.PubMedCrossRef
65.
go back to reference Sherman MJ, Raker CA, Phipps MG. Improving influenza vaccination rates in pregnant women. J Reprod Med. 2012;57(9–10):371–6.PubMed Sherman MJ, Raker CA, Phipps MG. Improving influenza vaccination rates in pregnant women. J Reprod Med. 2012;57(9–10):371–6.PubMed
66.
go back to reference Büsching U. [Implementation of the HPV recommendation - Evaluation of a survey in paediatrician's and adolescent's practices]. Pädiatrische Praxis. 2016;Band 85/4:535–44. (in German). Büsching U. [Implementation of the HPV recommendation - Evaluation of a survey in paediatrician's and adolescent's practices]. Pädiatrische Praxis. 2016;Band 85/4:535–44. (in German).
67.
go back to reference Larson H, de Figueiredo A, Karafillakis E, Rawa M. STATE OF VACCINE CONFIDENCE IN THE EU 2018. Luxembourg: European Commission; 2018. Larson H, de Figueiredo A, Karafillakis E, Rawa M. STATE OF VACCINE CONFIDENCE IN THE EU 2018. Luxembourg: European Commission; 2018.
68.
go back to reference Maertens K, Braeckman T, Top G, Van Damme P, Leuridan E. Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders. Belgium Vaccine. 2016;34(47):5785–91.PubMedCrossRef Maertens K, Braeckman T, Top G, Van Damme P, Leuridan E. Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders. Belgium Vaccine. 2016;34(47):5785–91.PubMedCrossRef
69.
go back to reference Vilca LM, Martinez C, Burballa M, Campins M. Maternal care Providers’ barriers regarding influenza and pertussis vaccination during pregnancy in Catalonia, Spain. Matern Child Health J. 2018;22(7):1016–24.PubMedCrossRef Vilca LM, Martinez C, Burballa M, Campins M. Maternal care Providers’ barriers regarding influenza and pertussis vaccination during pregnancy in Catalonia, Spain. Matern Child Health J. 2018;22(7):1016–24.PubMedCrossRef
70.
go back to reference Nicholl S, Seale H, Saul N, Campbell-Lloyd S. The importance of involving midwives before and during the implementation of an antenatal pertussis vaccination program in New South Wales, Australia. Women Birth. 2018. Nicholl S, Seale H, Saul N, Campbell-Lloyd S. The importance of involving midwives before and during the implementation of an antenatal pertussis vaccination program in New South Wales, Australia. Women Birth. 2018.
71.
go back to reference Mohammed H, Clarke M, Koehler A, Watson M, Marshall H. Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia. PLoS One. 2018;13(6):e0197867.PubMedPubMedCentralCrossRef Mohammed H, Clarke M, Koehler A, Watson M, Marshall H. Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia. PLoS One. 2018;13(6):e0197867.PubMedPubMedCentralCrossRef
72.
go back to reference Böhmer MM, Walter D, Krause G, Muters S, Gosswald A, Wichmann O. Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany. Hum Vaccin. 2011;7(12):1317–25.PubMedCrossRef Böhmer MM, Walter D, Krause G, Muters S, Gosswald A, Wichmann O. Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany. Hum Vaccin. 2011;7(12):1317–25.PubMedCrossRef
73.
go back to reference Böhmer MM, Walter D, Ehrhardt J, Reiter S, Krause G, Wichmann O. Seasonal and pandemic influenza vaccination: coverage and attitude among private physicians in Germany. Gesundheitswesen. 2014;76(1):44–7 (in German with English summary).PubMed Böhmer MM, Walter D, Ehrhardt J, Reiter S, Krause G, Wichmann O. Seasonal and pandemic influenza vaccination: coverage and attitude among private physicians in Germany. Gesundheitswesen. 2014;76(1):44–7 (in German with English summary).PubMed
74.
go back to reference Wortberg S, Walter D. Recallsystems in primary care practices to increase vaccination rates against seasonal influenza. Dtsch Med Wochenschr. 2010;135(22):1113–7 (in German with English summary).PubMedCrossRef Wortberg S, Walter D. Recallsystems in primary care practices to increase vaccination rates against seasonal influenza. Dtsch Med Wochenschr. 2010;135(22):1113–7 (in German with English summary).PubMedCrossRef
75.
go back to reference Hellenbrand W, Beier D, Jensen E, Littmann M, Meyer C, Oppermann H, et al. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis. 2009;9:22.PubMedPubMedCentralCrossRef Hellenbrand W, Beier D, Jensen E, Littmann M, Meyer C, Oppermann H, et al. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis. 2009;9:22.PubMedPubMedCentralCrossRef
Metadata
Title
Influenza and pertussis vaccination during pregnancy – attitudes, practices and barriers in gynaecological practices in Germany
Authors
Stefanie Böhm
Marianne Röbl-Mathieu
Burkhard Scheele
Michael Wojcinski
Ole Wichmann
Wiebke Hellenbrand
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-4437-y

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue